yeast
candida
albican
exist
dichotomist
relationship
human
host
c
albican
frequent
found
commens
organ
human
skin
gastrointestin
gi
tract
vulvovagin
tract
close
healthi
individu
carri
c
albican
commens
oral
caviti
colon
rectal
colon
even
higher
rang
among
patient
group
alter
host
immun
physiolog
normal
microflora
rather
acquisit
novel
hypervirul
factor
associ
c
albican
suggest
lead
develop
candidiasi
neutrophil
mucos
integr
gi
tract
critic
prevent
hematogen
dissemin
candidiasi
develop
candidemia
begin
transloc
c
albican
bloodstream
initi
commens
gi
colon
shed
develop
biofilm
indwel
cathet
fungal
cell
evad
host
immun
system
spread
deep
organ
system
lead
hematogen
dissemin
candidiasi
estim
mortal
rate
even
use
antifung
drug
inform
vivo
gene
express
would
provid
insight
c
albican
interact
host
cell
transit
commens
colon
opportunist
pathogen
immunocompromis
host
howev
vivo
transcript
profil
c
albican
commens
colon
candidemia
technic
challeng
instead
sever
genomewid
transcript
analys
c
albican
respons
host
cell
perform
use
ex
vivo
vivo
infect
model
includ
phagocytosi
c
albican
cell
neutrophil
macrophag
exposur
human
blood
plasma
blood
cell
well
invas
perfus
pig
liver
reconstitut
human
epithelium
gene
associ
morpholog
chang
metabol
adapt
oxid
stress
major
respons
c
albican
host
cell
identifi
studi
chang
gene
express
identifi
vitro
model
system
possibl
reflect
tissu
stagespecif
express
infect
patient
profil
antibodi
respons
infect
patient
offer
altern
approach
overcom
technic
challeng
vivo
transcript
profil
antibodybas
approach
use
identifi
c
albican
gene
express
thrush
individu
hiv
current
isol
c
albican
blood
cultur
standard
method
diagnosi
candidemia
nevertheless
blood
cultur
may
becom
posit
late
infect
one
studi
autopsyproven
case
candidemia
report
neg
blood
cultur
thu
abil
rapidli
easili
diagnos
candidiasi
urgent
need
altern
approach
microbiolog
confirm
c
albican
infect
serolog
diagnosi
immunoproteom
approach
use
twodimension
electrophoresi
follow
quantit
western
blot
mass
spectrometri
use
profil
serolog
respons
peptid
cell
surfac
extract
candidemia
signific
proport
antigen
identifi
glycolyt
enzym
heat
shock
protein
antigen
multiplex
consist
peptid
provid
sensit
specif
distinguish
patient
candidemia
uninfect
hospit
patient
howev
approach
sever
limit
abund
solubl
protein
resolv
immunoblot
lack
reproduc
cell
wall
prepar
importantli
inabl
account
variou
stage
tissuespecif
gene
express
cultur
cell
limit
address
use
protein
microarray
profil
antibodi
respons
investig
establish
humor
immun
commens
sensit
well
adapt
immun
respons
candidemia
develop
c
albican
cell
surfac
protein
microarray
rational
develop
cell
surfac
protein
microarray
cell
surfac
c
albican
immedi
target
human
immun
system
c
albican
cell
enter
bloodstream
cell
surfac
protein
play
import
role
host
interact
mani
known
virul
factor
addit
recent
studi
show
signific
expans
cell
wall
secret
transport
gene
famili
pathogen
candida
speci
comparison
nonpathogen
yeast
studi
profil
serolog
respons
protein
microarray
sera
candidemia
patient
bloodcultur
neg
hospit
patient
healthi
individu
lead
identif
serolog
signatur
specif
acut
convalesc
stage
candidemia
intriguingli
larg
proport
identifi
antigen
involv
oxid
stress
drug
resist
iron
acquisit
furthermor
strong
igg
respons
mani
protein
known
induc
andor
requir
c
albican
invas
epitheli
endotheli
cell
observ
candidemia
patient
noncandidemia
control
includ
healthi
individu
find
provid
new
insight
commens
colon
pathogenesi
c
albican
well
character
potenti
serodiagnost
antigen
vaccin
candid
hospit
patient
sera
collect
shand
hospit
univers
florida
uf
shuf
januari
decemb
collect
sera
patient
candidemia
etiolog
agent
c
albican
median
time
date
posit
cultur
serum
collect
two
day
studi
popul
classifi
age
gender
underli
diseas
portal
entri
antifung
receiv
outcom
stay
tabl
subset
candidemia
patient
follow
acut
infect
day
earli
convalesc
week
mid
convalesc
week
infect
also
use
sera
hospit
patient
healthi
individu
evid
candidiasi
neg
control
group
c
albican
cell
surfac
protein
chosen
protein
microarray
interact
directli
host
thu
like
import
colon
infect
well
like
target
host
immun
system
furthermor
mani
protein
express
level
regul
respons
extracelluar
signal
stress
nutrient
host
factor
chang
environ
known
antigen
protein
also
includ
control
member
famili
collect
contain
hatag
peptid
tabl
repres
differ
protein
sinc
orf
bp
clone
two
segment
tag
protein
confirm
individu
western
blot
protein
microarray
use
c
albican
cell
surfac
microarray
evalu
antibodi
profil
patient
candidemia
healthi
individu
uninfect
hospit
patient
determin
relev
cell
surfac
antigen
correl
infect
array
probe
collect
sera
consist
differ
stage
candidemia
acut
earli
convalesc
approxim
week
onset
infect
mid
convalesc
approxim
week
onset
infect
well
uninfect
hospit
patient
healthi
individu
figur
show
repres
imag
microarray
hybrid
serum
acut
candidemia
patient
hybrid
studi
done
condit
dilut
protein
microarray
print
batch
serolog
reactiv
shown
heatmap
antigen
sort
increas
normal
global
mean
intens
bright
green
weakest
intens
red
strongest
black
figur
examin
igg
respons
entir
c
albican
cell
surfac
protein
microarray
show
mean
global
signal
intens
similar
among
differ
group
data
shown
although
antigen
profil
ident
individu
interest
determin
seropreval
antibodi
acut
candidemia
patient
humor
respons
compar
neg
control
group
antigen
seropreval
antibodi
defin
serodomin
antigen
character
mean
antigen
reactiv
greater
vitro
transcriptiontransl
reaction
mixtur
contain
vector
topforti
serodomin
antigen
candidemia
patient
consist
mani
previous
character
antigen
peptid
tabl
also
among
topforti
serodomin
antigen
mani
previous
identifi
virulenceassoci
andor
hyphalregul
protein
eg
tabl
interestingli
serolog
respons
acut
candidemia
patient
share
uninfect
hospit
patient
healthi
individu
mean
signal
intens
topforti
serodomin
antigen
acut
candidemia
patient
uninfect
hospit
patient
healthi
individu
twoway
hierarch
cluster
analysi
topforti
serodomin
antigen
show
serum
specimen
posit
neg
candidemia
group
randomli
dispers
throughout
hierarch
tree
figur
confirm
topforti
serodomin
antigen
signatur
share
among
acut
candidemia
patient
uninfect
hospit
patient
healthi
individu
princip
compon
analysi
pca
use
gener
threedimension
project
data
figur
pca
show
larg
proport
posit
neg
acut
candidemia
sera
cluster
togeth
analys
suggest
igg
level
topforti
serodomin
antigen
similar
neg
control
group
acut
candidemia
sera
sinc
mani
topforti
antigen
either
import
induc
invas
epitheli
endotheli
cell
express
healthi
peopl
infer
presenc
antibodi
indic
exist
perman
hostpathogen
interplay
immunocompet
individu
determin
stagespecif
biomark
acut
candidemia
normal
serolog
express
acut
candidemia
patient
compar
humor
reactiv
uninfect
hospit
patient
healthi
individu
serodiagnost
antigen
defin
igg
respons
significantli
greater
acut
candidemia
patient
day
compar
neg
control
group
benjamini
hochberg
bh
adjust
cybert
pvalu
thirteen
antigen
met
requir
tabl
moreov
among
protein
identifi
serodiagnost
marker
protein
involv
oxid
stress
respons
appear
enrich
function
categori
two
three
histidin
kinas
cell
surfac
protein
microarray
identifi
serodiagnost
antigen
sensor
highosmolar
glycerol
hog
pathway
mitogenactiv
protein
kinas
cascad
respons
osmot
oxid
stress
adapt
c
albican
addit
express
level
upregul
oxid
stress
anoth
function
group
overrepres
among
serodiagnost
antigen
transport
associ
drug
resist
antigen
also
evalu
twoway
hierarch
cluster
analysi
candidemia
posit
neg
sera
interestingli
sera
cluster
two
distinct
group
base
respons
antigen
figur
cluster
contain
candidemia
sera
one
uninfect
hospit
patient
cluster
ii
contain
healthi
individu
hospit
patient
acut
candidemia
sera
figur
confirm
antigen
signatur
identifi
acut
phase
candidemia
differ
neg
control
group
pca
use
creat
threedimension
project
data
figur
agreement
twoway
hierarch
cluster
analysi
two
distinct
group
observ
figur
also
pca
neg
control
group
show
individu
cluster
togeth
except
one
outli
uninfect
hospit
patient
found
cluster
acut
candidemia
patient
figur
data
provid
support
antigen
signatur
patient
acut
phase
candidemia
multipl
linear
regress
model
determin
antigen
profil
acut
candidemia
patient
relat
variou
risk
factor
ie
age
gender
cours
treatment
coexist
diseas
recoveryfat
data
shown
howev
determin
limit
small
sampl
size
studi
multipl
independ
serodiagnost
antigen
dramat
improv
sensit
accuraci
serodiagnost
test
establish
collect
antigen
could
use
multiplex
set
accur
distinguish
candidemia
case
control
studi
discriminatori
power
differ
set
protein
use
receiv
oper
characterist
roc
curv
first
roc
curv
gener
individu
serodiagnost
antigen
area
roc
curv
auc
antigen
list
tabl
topfiv
cell
surfac
protein
auc
greater
auc
bh
adjust
cybert
pvalu
give
best
singl
antigen
discrimin
tabl
antigen
auc
still
exce
upper
confid
interv
random
expect
auc
extend
analysi
combin
antigen
use
kernel
method
support
vector
machin
build
linear
nonlinear
classifi
input
classifi
use
highestrank
auc
antigen
combin
protein
result
valid
run
threefold
crossvalid
figur
increas
antigen
number
produc
improv
classifi
antigen
increas
reduct
accuraci
observ
use
ten
signific
diagnost
antigen
rank
order
classifi
predict
ci
sensit
ci
specif
ci
accuraci
diagnosi
acut
phase
candidemia
neg
control
healthi
individu
uninfect
hospit
patient
tabl
next
interest
identifi
antigen
significantli
differ
earlymid
convalesc
candidemia
patient
week
infect
respect
neg
control
group
convalesc
patient
sera
consist
three
patient
whose
serum
drawn
three
diseas
phase
acut
phase
earli
mid
convalesc
phase
patient
blood
drawn
acut
earli
convalesc
phase
patient
whose
blood
drawn
earli
convalesc
phase
use
bh
adjust
cybert
pvalu
identifi
antigen
diagnost
antigen
acut
phase
infect
tabl
among
identifi
convalesc
biomark
mark
expans
protein
involv
iron
acquisit
tabl
put
ferric
reductas
similar
requir
releas
iron
transferrin
reduct
ferrou
iron
protein
identifi
heme
uptak
activ
wherea
implic
receptor
hemoglobin
whose
function
deliv
hemoglobin
endocystosi
vacuol
iron
releas
acidif
remaind
identifi
protein
role
cell
wall
biogenesi
membran
lipid
organ
drug
resist
next
evalu
antibodi
respons
antigen
acut
convalesc
candidemia
patient
neg
control
group
twoway
hierarch
cluster
analysi
individu
cluster
ii
identifi
previous
serodiagnost
antigen
figur
addit
one
convalesc
candidemia
patient
whose
sera
drawn
week
infect
individu
cluster
consist
candidemia
patient
except
one
uninfect
hospit
patient
figur
three
candidemia
patient
acut
convalesc
profil
found
cluster
wherea
four
candidemia
patient
profil
convert
cluster
ii
convalesc
phase
diseas
addit
remain
twocandidemia
patient
whose
blood
draw
week
also
group
cluster
figur
convers
antigen
profil
neg
control
group
cluster
ii
antigen
profil
consist
candidemia
cluster
indic
adapt
immun
respons
c
albican
differ
commens
sensit
pca
use
confirm
antigen
signatur
identifi
convalesc
phase
candidemia
differ
neg
control
group
figur
roc
curv
gener
assess
abil
separ
control
convalesc
candidemia
auc
determin
antigen
list
tabl
decreas
order
topfiv
orf
auc
greater
use
svm
build
multiplex
classifi
antigen
highestrank
auc
tabl
result
valid
run
threefold
crossvalid
figur
increas
antigen
number
maintain
diagnost
accuraci
classifi
reduct
accuraci
occur
antigen
increas
due
overfit
topfiv
serodiagnost
antigen
associ
xenobiotictransport
activ
phospholipidtransport
activ
put
ferric
reductas
mucinlik
cell
wall
protein
tabl
use
topfiv
antigen
classifi
predict
ci
sensit
ci
specif
ci
accuraci
differenti
earlymid
convalesc
phase
candidemia
neg
control
healthi
individu
uninfect
hospit
patient
tabl
identifi
antigen
correl
convalesc
candidemia
comparison
neg
control
group
next
want
determin
tempor
chang
igg
respons
antigen
transit
acut
infect
ai
earli
convalesc
ec
mid
convalesc
mc
twoway
hierarch
cluster
analys
perform
differenti
igg
respons
antigen
patient
ai
ec
mc
sera
patient
ai
ec
sera
figur
one
tail
ttest
carri
look
differ
ec
antigen
intens
significantli
greater
ai
antigen
intens
possibl
indic
select
protect
antibodi
respons
observ
signific
increas
igg
respons
ai
ec
follow
antigen
rank
accord
pvalu
identifi
antigen
could
potenti
efficaci
vaccin
candid
due
fact
igg
respons
posit
select
cours
infect
studi
develop
c
albican
cell
surfac
protein
microarray
profil
host
humor
respons
conmmens
colon
progress
candidemia
thirteen
novel
serodiagnost
antigen
identifi
differenti
acut
candidemia
commens
sensit
antigen
found
discrimin
convalesc
candidemia
noncandidemia
control
sensit
specif
identif
acut
candidemia
determin
top
antigen
set
serodiagnost
marker
compar
obtain
use
method
immunoblot
use
top
antigen
set
sensit
specif
dramat
improv
convalesc
candidemia
pitarch
et
al
report
igg
antibodi
level
mainli
defin
proteom
signatur
candidemia
patient
studi
list
diagnost
antigen
convalesc
sera
although
classifi
serodomin
antigen
acut
candidemia
sera
bhadjust
pvalu
cutoff
consid
diagnost
definit
mean
antibodi
acut
candidemia
higher
mean
noncandidemia
control
glycoprotein
glycan
moieti
seem
contribut
antigen
sinc
express
vitro
without
glycosyl
antigen
like
differ
produc
c
albican
use
immunoblot
previous
identifi
immunogen
heat
shock
protein
also
one
biomark
convalesc
candidemia
identifi
studi
shown
elicit
protect
humor
respons
antibodi
known
associ
patient
recov
candidiasi
use
protein
microarray
technolog
allow
us
identifi
new
diagnost
antigen
miss
previou
studi
use
page
accur
identifi
separ
clinic
marker
candidemia
commens
sensit
limit
rang
protein
abund
variou
properti
associ
peptid
mass
isoelectr
point
hydrophob
posttransl
modif
well
semiquantit
natur
western
use
c
albican
cell
surfac
protein
microarray
help
us
overcom
mani
technic
difficulti
found
tradit
proteom
sinc
express
level
recombinantderiv
protein
vari
singl
log
use
fluorescentlabel
antibodi
allow
greater
linear
precis
sensit
quantit
measur
humor
respons
c
albican
one
benefici
aspect
use
protein
microarray
assay
abil
detect
signific
differ
igg
respons
tradit
immunoblot
condit
would
detect
threshold
howev
potenti
limit
studi
microarray
base
recombin
peptid
cell
free
natur
vitro
translat
peptid
potenti
epitop
may
lost
due
miss
fold
lack
glycosyl
may
affect
conform
structur
nativ
protein
hand
remov
posttransl
modif
glycosyl
peptid
may
reveal
hidden
peptid
epitop
seen
strong
host
immun
respons
larg
collect
peptid
epitop
may
increas
specif
diagnosi
infect
support
studi
identifi
mani
new
clinic
biomark
associ
differ
state
interact
host
well
character
potenti
new
target
therapeut
vaccin
candid
knowledg
first
studi
use
protein
microarray
analyz
serolog
respons
organ
capabl
exist
commens
flora
opportunist
pathogen
human
popul
commens
colon
c
albican
common
human
attenu
host
immun
perquisit
transit
commens
colon
infect
histor
believ
c
albican
switch
commens
pathogen
use
distinct
pathogenassoci
genet
program
host
immun
statu
alter
intrigu
review
challeng
notion
hube
postul
c
albican
exist
perman
hostpathogen
interplay
overgrowth
invas
observ
immunocompromis
condit
review
put
forth
twomodel
perman
infect
strategi
constitut
gene
express
attenu
immun
induc
littl
chang
pathogen
profil
c
albican
variabl
transcript
profil
c
albican
express
depend
stage
tissuespecif
interact
host
studi
indic
exist
perman
hostpathogen
interplay
variabl
gene
express
cours
infect
serolog
respons
entir
c
albican
cell
surfac
protein
microarray
detect
consider
homogen
well
differ
pattern
antigen
recogn
among
patient
healthi
individu
major
healthi
individu
uninfect
hospit
patient
moder
strong
igg
respons
mani
c
albican
cell
surfac
protein
long
associ
virul
hyphalregul
hallmark
virul
agreement
protein
microarray
data
naglik
et
al
observ
similar
level
igg
titer
hyphal
wall
protein
patient
oral
candidiasi
asymptomat
mucos
infect
well
healthi
cultureneg
control
serodomin
crossreact
antigen
includ
adhesin
hyphalregul
gene
function
group
known
import
invas
virul
among
identifi
serodomin
antigen
mani
previous
character
immunogen
peptid
intriguingli
averag
signal
intens
topforti
serodomin
antigen
higher
healthi
individu
uninfect
hospit
patient
acut
candidiasi
patient
vs
respect
interest
specul
whether
healthi
individu
igg
respons
limit
colon
overgrowth
sinc
mani
serodomin
antigen
adhesin
particular
strong
humor
respons
integrinlik
protein
may
play
dual
role
limit
intestin
colon
cecum
system
invas
deep
tissu
organ
anoth
interest
serodomin
antibodi
respons
protein
shown
promot
adhes
import
gi
colon
transcript
highli
express
gi
colon
invas
host
tissu
howev
one
discount
high
igg
titer
colon
individu
may
due
previou
superfici
infect
candid
vagin
microenvironment
condit
commens
colon
host
may
also
play
role
induct
igg
respons
certain
cell
surfac
protein
previou
studi
evalu
characterist
common
gi
andor
vulvovagin
tract
blood
hypoxia
iron
restrict
weak
acid
modifi
gene
express
intriguingli
express
gene
share
common
featur
identifi
serodomin
antibodi
interestingli
gene
transcript
upregul
blood
serodomin
crossreact
posit
neg
candidiasi
individu
gene
upregul
hypox
condit
iron
restrict
weak
acid
tabl
furthermor
serodomin
antigen
ie
shown
induc
invas
epitheli
endotheli
cell
therefor
express
serodomin
antigen
healthi
individu
indic
exist
perman
hostpathogen
interplay
commens
colon
addit
presenc
serodomin
igg
healthi
individu
suggest
commens
colon
much
preval
previous
report
one
challeng
task
character
serodiagnost
antigen
c
albican
identif
discrimin
peptid
differenti
commens
colon
candidemia
high
sensit
specif
profil
antibodi
respons
patient
vari
stage
candidemia
healthi
individu
candidemianeg
hospit
patient
identifi
diagnost
antigen
acut
phase
candidemia
earlymid
convalesc
candidemia
serolog
signatur
candidemia
patient
like
reflect
alter
level
protein
due
chang
either
transcript
andor
protein
stabil
stage
tissuespecif
gene
express
cours
system
infect
expect
c
albican
cell
transit
differ
microenviron
host
among
diagnost
antigen
acut
candidemia
three
associ
drug
resist
exposur
antifung
drug
patient
undergo
acut
candidemia
may
act
addit
environment
stress
stimul
express
antifung
drug
transport
intriguingli
two
biomark
osmosensor
hog
pathway
respons
osmot
oxid
stress
adapt
c
albican
hostpathogen
interact
commonli
associ
oxid
stress
typic
seen
phagocytosi
neutrophil
initi
immun
respons
c
albican
overgrowth
infect
furthermor
studi
global
transcript
respons
oxid
stress
observ
increas
transcript
express
taken
togeth
data
indic
strong
correl
igg
respons
oxid
stressrel
cell
surfac
protein
initi
cellmedi
immun
respons
acut
candidemia
agreement
previou
studi
shown
oxid
stress
function
primarili
induc
c
albican
initi
expos
human
blood
follow
phagocytosi
neutrophil
granulocyt
convalesc
diagnost
antigen
includ
protein
involv
iron
acquisit
cell
wall
biogenesi
membran
lipid
organ
drug
resist
particular
interest
dramat
increas
antibodi
protein
iron
acquisit
ferric
reductas
hemoglobin
receptor
heme
uptak
iron
essenti
nutrient
c
albican
circul
iron
serum
bound
transferrin
ferric
reductas
requir
acquisit
iron
transferrin
interestingli
found
biomark
acut
convalesc
candidemia
patient
particular
interest
increas
antibodi
respons
hemoglobin
hemerel
protein
molecul
normal
sequest
erythrocyt
protein
requir
iron
acquisit
hemoglobin
heme
diagnost
antigen
convalesc
candidemia
thu
interest
specul
whether
free
hemoglobin
becom
byproduct
lyse
erythrocyt
postop
surgeri
invas
clinic
procedur
nevertheless
data
studi
provid
critic
inform
develop
diagnost
antigen
profil
patient
risk
candidemia
assess
progress
hematogen
dissemin
candidiasi
futur
studi
need
done
determin
whether
serolog
differ
exist
superfici
system
infect
well
commens
sensit
develop
antigen
profil
cours
candidiasi
acut
infect
earli
convalesc
mid
convalesc
may
also
provid
insight
protect
humor
respons
c
albican
even
though
previou
sensit
commens
colon
limit
mortal
even
morbid
patient
experiment
studi
identifi
protect
antibodi
hematogen
dissemin
candidiasi
heat
shock
protein
futur
studi
need
address
whether
serodiagnost
antigen
identifi
studi
could
provid
protect
hematogen
dissemin
candidiasi
particular
interest
convalesc
serodiagnost
antigen
ec
antigen
intens
significantli
greater
ai
antigen
intens
may
possibl
indic
select
protect
antibodi
respons
human
sera
candidemia
patient
hospit
patient
collect
shuf
protocol
approv
creat
uf
institut
review
board
sera
healthi
individu
obtain
volunt
gener
clinic
research
center
univers
california
irvin
written
inform
consent
obtain
particip
candidemia
defin
recoveri
c
albican
blood
cultur
sera
candidemia
patient
hospit
patient
clinic
microbiolog
evid
candidemia
collect
shuf
previous
publish
briefli
patient
shuf
identifi
day
blood
cultur
posit
c
albican
infecti
diseas
consult
servic
shuf
identifi
control
sera
collect
store
repositori
uf
mycolog
research
unit
patient
candidemia
sera
obtain
earliest
possibl
date
date
first
posit
cultur
drawn
case
within
day
first
posit
cultur
acutephas
sera
ten
patient
candidemia
sera
also
recov
week
date
first
posit
cultur
drawn
convalescentphas
sera
cell
surfac
protein
select
candida
genom
databas
cgd
use
keyword
cell
surfac
plasma
membran
cell
wall
cgd
annot
cell
surfac
protein
base
publish
experi
functionbas
predict
cellular
local
sequenc
predict
known
antigen
protein
also
includ
control
member
famili
code
region
gene
pcr
amplifi
clinic
isol
c
albican
primer
list
tabl
clone
express
vector
hatag
nterminu
histag
cterminu
homolog
recombin
e
coli
describ
protein
express
carri
use
e
coli
base
cellfre
vitro
transcriptiontransl
system
rt
e
coli
hy
kit
roch
protein
microarray
made
print
peptid
onto
nitrocelluloseco
fast
glass
slide
schleicher
schuell
use
omnigrid
genemachin
uci
microarray
facil
peptid
print
duplic
show
homogen
spot
morpholog
well
low
background
intern
control
consist
buffer
alon
reaction
mixtur
dna
also
print
onto
fast
slide
addit
plasma
sampl
microarray
incub
biotinconjug
donkey
antihuman
igg
fragment
specif
secondari
antibodi
jackson
immunoresearch
secondari
antibodi
remov
microarray
incub
streptavidin
surelight
columbia
bioscienc
detail
concern
microarray
construct
control
antibodi
profil
data
normal
well
reproduc
valid
microarray
given
text
analysi
perform
use
r
statist
environ
http
wwwrprojectorg
note
literatur
data
deriv
microarray
platform
heteroskedat
meanvari
depend
observ
array
present
manuscript
order
stabil
varianc
vsn
method
implement
part
bioconductor
suit
wwwbioconductororg
appli
quantifi
array
intens
addit
remov
heteroskedac
procedur
correct
nonspecif
nois
effect
find
maximum
likelihood
shift
scale
paramet
array
varianc
larg
number
default
set
use
spot
array
minim
word
method
assum
varianc
bind
vast
major
protein
array
due
nois
rather
true
differenti
immunolog
respons
essenc
spot
array
use
control
samplebysampl
normal
calibr
method
shown
effect
number
platform
simpl
rank
normal
protein
order
sampl
bind
intens
assign
integ
rank
perform
well
similar
result
result
shown
final
vsn
normal
data
retransform
sinh
function
allow
visual
discuss
approxim
raw
scale
diagnost
biomark
group
determin
use
bay
regular
ttest
adapt
cybert
protein
array
account
multipl
test
condit
benjamini
hochberg
bh
method
use
control
fals
discoveri
rate
statist
analys
perform
r
wwwrprojectorg
stata
version
statacorp
multipl
antigen
classifi
construct
use
linear
nonlinear
support
vector
machin
svm
use
r
packag
prevent
overfit
show
gener
classif
method
repeat
threefold
crossvalid
perform
methodolog
data
split
classstratifi
subset
subset
classifi
train
use
remain
twothird
data
classifi
evalu
onethird
data
use
train
process
repeat
split
differ
split
yield
evalu
measur
rocr
packag
use
construct
receiveroperatingcharacterist
curv
perform
sensit
specif
analys
use
gene
ontolog
annot
enrich
analysi
confirm
identifi
antigen
accur
vector
resequenc
tabl
list
statist
data
acut
convalesc
candidemia
patient
respect
detail
inform
genesprotein
studi
found
candida
genom
databas
http
wwwcandidagenomeorg
gene
name
orf
number
list
